Fomerly known as Goodwin Biotechnology Inc.





When speed, quality, and flexibility matter for every stage of your biotherapeutics project, choose GBI as your CDMO partner.

Learn More

GBI is a full-service biopharmaceutical CDMO based in Florida that aims to eliminate manufacturing risk for companies developing complex biologic therapeutics.

Our responsive teams of experts across development, manufacturing, project management, and quality can leverage our many platforms to move your project forward on time and on budget.

With an extensive offering of development services, state-of-the-art manufacturing equipment, and project support, GBI is truly a full-service CDMO biologics partner. Our approach pairs our expert knowledge base with an open mind towards scientific discovery so that together we can develop an optimal way to make our systems work for you and your biologics project, no matter how complex it may be.

End-to-End Biomanufacuring Services - All Under One Roof: USP Cell Culture Development, cGMP Cell Banking, DSK Purification Development, cGMP Clinical & Commercial Manufacuring, Bioconjugation, Aseptic Full & Finish, Stability Testing, and Analytical Method Development, Assay Verification & Characterization.
Biopharmaceutical Manufacturing

Our Single-Source Solution™

GBI’s Single-Source Solution™ offers a wide breadth of integrated CDMO biologics services that are specifically tailored to your needs during manufacturing strategy development. Regardless of your project’s stage, our slate of development and manufacturing services are available to help ensure that your project is completed efficiently and safely.

Explore GBI's Manufacturing Services
Support Services

Manufacturing Strategy Development

GBI’s manufacturing strategy development team will walk you through what needs to be done to keep your project on time, in compliance, and within budget.

Learn More

Project Management

Stay in the loop and feel comfortable knowing GBI’s expertise is keeping your project on track with our transparent and proactive approach to project management.

Learn More

Regulatory & CMC Support

No matter where in the world you are, GBI brings expert support to help you quickly and effectively move your drug candidates through the regulatory application and review process.

Learn More

Quality Control & Quality Assurance

Every one of our departments involved in cGMP manufacturing maintains a quality program that meets that department’s specific needs.

Learn More

Biomanufacturing Planning

GBI will review your requirements and share our process development and manufacturing expertise to design the appropriate technical, quality, CMC, and regulatory strategies for your biopharmaceutical candidate.

Learn More
Female scientist working at Desktop Computer
Two female scientists talking over clipboard
Male scientist using microscope
Two scientists talking over laminated paper
Female scientist working at laboratory equipment
Three tier ring decribing GBI Bio's Quality by Design Process: Inner ring: Product Specifications and Performance, Critical Quality Attributes and Characterization,Process Design and Parameters, and Process Design and Performance. Middle ring: Product Knowledge, and Process Understanding. Outer ring: Continuous Improvement, Rsk Assessment, and Life Cyclle Management.
  • Bioconjugation

    GBI will help you face the unique challenges of producing and fully characterizing biosimilars.

  • Complex Biologics

    GBI is strongly positioned for the growing focus in biopharmaceuticals on the development of complex biologics that allow the targeted delivery of products with multiple functionalities.

Read More

News and Resources

News From GBI

Press Releases Jan 15, 2024

GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing


BIO International Convention

June 3-6, 2024 San Diego Convention Center
111 West Harbor Drive, San Diego
CA, 92101
Publications & Patents May 7, 2024

Antibody-Oligonucleotide Conjugates Clinical Manufacturing – A new paradigm shift of Bio-Conjugates for Therapeutics

Blog May 7, 2024

GBI Role in Bioconjugation for Radiopharmaceuticals and Other Emerging Therapies

News Mar 15, 2024

Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool

News Mar 8, 2024

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Blog Feb 29, 2024

Overcoming Scalability in Biologics: CDMO Strategies for Success

Blog Feb 9, 2024

Sandra Isaacs, Director, Quality Assurance Department – Women in STEM

Blog Feb 9, 2024

Maria F. Lechuga, Biochemist, Sr. Manager of Quality Control Analytical Department – Women in STEM

Blog Jan 16, 2024

Future Trends in Sterile Fill Finish Technology: What’s on the Horizon?

Read All News
Two scientists examining a test tube


Join GBI’s team of dedicated scientists and other talented professionals in Florida as we expand into a larger facility and a bigger future.

Explore our Opportunities

Contact Us

    * mandatory fields